House Spending Panel Drops U.S. Ban on Gene-edited Babies
Published:12 Jun.2019    Source:Sciencemag

A Democrat-led spending panel in the U.S. House of Representatives has dropped a provision that banned embryo editing with the intention of creating a baby. The draft bill is still moving through the legislative process, however, and Republicans will likely push to restore the language. The ban was first added to the law that funded the U.S. government in 2016. It bars the Food and Drug Administration (FDA) from considering any clinical trial application. Although a different “rider” bars the National Institutes of Health (NIH) from funding human germline editing—or the genetic modification of sperm, eggs, or embryos—such work is permissible with private funding. However, researchers would need FDA approval for a clinical trial.